Buying a Chinese Company Before the 2027 Registered-Capital Transition Deadline

A foreign investor agrees to buy 100% of a Chinese limited liability company established in 2018.

The target has RMB 50 million registered capital. Only RMB 15 million has been paid. The old articles say the remaining RMB 35 million is due in 2034.

The seller tells the buyer:

The specific issue#

“Don't worry. China used a subscription system. The unpaid amount is normal.”

That statement is no longer enough.

The revised Company Law took effect on July 1, 2024 and introduced a general five-year contribution period for new limited liability companies. The State Council's implementation rules create a transition for older companies and require certain companies with long remaining contribution periods to adjust by June 30, 2027.^[1][2]

For an M&A buyer, the real question is:

Who will ultimately fund the unpaid capital, what historical liabilities are attached to it, and how should the SPA allocate that risk?

This article analyzes that issue in detail.

1. Article 47 changes the default capital timetable#

Article 47 of the revised Company Law states that the registered capital of a limited liability company is the total amount subscribed by shareholders and generally requires shareholders to fully pay subscribed capital within five years from company establishment, subject to special rules.^[1]

For new companies, the legal direction is clear.

For legacy companies, the State Council transition rule must be applied.

2. Article 2 of the transition rules creates the 2027 milestone#

The State Council's 2024 registered-capital provisions state that for companies established on or before June 30, 2024, where the remaining contribution period calculated from July 1, 2027 exceeds five years, the company must adjust the remaining contribution period to within five years by June 30, 2027 and record the revised period in the articles.^[2]

This means the 2018 target with a 2034 due date cannot be analyzed under the old articles alone.

The buyer should ask:

• Has the company already amended the contribution timetable?
• Will the seller do so before closing?
• Will closing occur before or after June 30, 2027?
• Who will fund the unpaid amount?

The answer belongs in the SPA.

3. Reconstruct the complete contribution history#

Diligence should not begin with the current business license.

Build a capital history from incorporation to signing.

Documents:

• original articles;
• amended articles;
• shareholder register;
• contribution certificates;
• bank records;
• accounting records;
• foreign investment remittance records;
• valuation reports for non-cash contributions;
• equity-transfer documents;
• capital increase/reduction documents.

The goal is to answer:

Who promised what, when, and what was actually delivered?

4. Non-cash contributions require separate verification#

Article 48 allows certain non-cash property, including IP, land-use rights, equity and claims, to be used as capital if it can be valued in money and legally transferred, subject to statutory restrictions. Such property should be valued and verified.^[1]

A buyer should therefore verify:

• legal ownership;
• valuation;
• transfer to the company;
• registration where required;
• ongoing encumbrance.

An IP contribution that was never legally assigned may mean the target does not own what its capital records suggest.

5. Article 49 creates direct contribution obligations#

Article 49 requires shareholders to make contributions in full and on time according to the articles and provides for liability where they fail to do so.^[1]

This means unpaid capital is not simply “authorized capital.”

It is an actual shareholder obligation.

The buyer must understand whether the obligation follows the transferred equity, remains with the seller, or creates overlapping exposure under applicable rules.

The SPA should not leave the issue to inference.

6. Equity-transfer diligence should identify historic unpaid capital#

Suppose the seller acquired the shares from an earlier shareholder in 2021.

The buyer should review:

• whether capital was already due at that time;
• what the 2021 SPA said;
• whether the original shareholder remained liable in any respect;
• whether the current seller assumed funding obligations.

Historic transfers can create a chain of potential claims.

A clean current shareholder register does not tell the full story.

7. Article 54 acceleration risk should be considered#

The revised Company Law includes circumstances in which shareholders may be required to make contributions earlier than the scheduled date where the company cannot pay due debts.^[1]

This means a company under financial distress can turn a future contribution obligation into a near-term liquidity demand.

The buyer should therefore analyze unpaid capital together with:

• solvency;
• overdue debt;
• litigation;
• guarantees;
• cash flow.

A company with RMB 30 million unpaid capital and significant overdue debt presents a different risk from a profitable company with the same nominal capital gap.

8. Directors' capital oversight duties matter#

The revised Company Law strengthens corporate governance around capital contributions.

The buyer should examine whether the company has internal records or notices concerning unpaid contributions and whether directors took required actions.

This matters because post-closing directors may inherit responsibility for governance of the capital process.

The buyer should not close and only then ask who monitors contribution deadlines.

9. The purchase price should reflect economic funding#

If the buyer will have to inject RMB 35 million after closing, the equity price should be negotiated with that future cash requirement in mind.

Three common economic structures are:

Structure A: seller contributes before closing#

Buyer acquires fully funded company.

Structure B: price reduced#

Buyer accepts future contribution obligation but pays lower purchase price.

Structure C: escrow/holdback#

Part of price retained until contribution issue resolved.

The correct structure depends on tax, financing and negotiation.

But the SPA should state the economic allocation explicitly.

10. A representation alone may be insufficient#

The seller might represent: “all capital contribution obligations have been complied with.”

If that representation is false, the buyer has a damages claim.

But if the company needs cash immediately, a damages claim may not solve the operational problem.

Specific protections may include:

• pre-closing contribution condition;
• specific indemnity;
• escrow;
• purchase-price adjustment;
• parent guarantee.

The buyer should choose the remedy based on liquidity needs.

11. The SPA should define the capital schedule#

A strong SPA can include a schedule listing:

• registered capital;
• paid-in capital;
• unpaid amount;
• responsible shareholder;
• due date;
• evidence.

This avoids ambiguity.

The schedule should be cross-checked against company records.

12. Capital reduction can be a pre-closing remediation option#

If registered capital is commercially excessive, the seller may propose reduction before closing.

The buyer should analyze:

• creditor-protection procedures;
• timing;
• solvency;
• effect on licenses or financing;
• registration;
• whether reduction is genuine or designed only to avoid contribution.

Capital reduction can be legitimate, but it should not be rushed without creditor analysis.

13. Article 3 of the State Council rules allows scrutiny of abnormal capital#

The State Council provisions state that where contribution periods or registered capital are obviously abnormal, the registration authority may consider the company's business scope, operations, shareholder contribution ability, main projects and asset scale and require adjustment where authenticity or reasonableness concerns arise.^[2]

A buyer should therefore identify targets with:

• enormous registered capital;
• minimal assets;
• very long contribution periods;
• weak shareholder funding ability.

Those characteristics can create regulatory attention.

14. Foreign-invested targets require an additional funding-path review#

For a foreign-invested target, unpaid capital may need to be funded from overseas.

The buyer should map:

• post-closing shareholder;
• currency;
• bank process;
• foreign exchange documentation;
• corporate approvals.

A contractual promise to contribute is only useful if the money can move on time.

15. Financing documents may contain capital covenants#

Target bank loans may require:

• minimum registered capital;
• shareholder support;
• no capital reduction;
• change-of-control consent.

The buyer should review financing documents before agreeing to capital remediation.

A capital reduction that solves Company Law concerns could breach a loan covenant.

16. Government incentive agreements can also depend on capital#

Industrial park or investment agreements may link incentives to:

• registered capital;
• total investment;
• paid-in capital;
• production milestones.

Changing capital may affect:

• subsidies;
• land price;
• tax incentives;
• clawback.

Vendor diligence should capture these agreements.

17. Case study: foreign buyer of manufacturing target#

Target:

• established 2018;
• registered capital RMB 50m;
• paid RMB 15m;
• remaining due 2034;
• bank debt RMB 20m;
• industrial park incentive linked to paid-in capital;
• seller is a private founder.

Buyer plans closing in March 2027.

Buyer risk#

If the seller transfers shares without resolving the capital timetable, the buyer may soon face:

• article amendment;
• accelerated funding;
• incentive consequences;
• lender questions.

Better structure#

Possible terms:

• seller amends articles before closing;
• seller contributes RMB 20m before closing;
• buyer assumes RMB 15m post-closing;
• price reduced accordingly;
• specific indemnity for historic contribution breaches;
• lender consent obtained.

This is a commercial allocation, not merely a legal disclosure.

18. Diligence questions for the seller#

• What is registered capital?
• What is paid in?
• Who paid each contribution?
• Were any contributions non-cash?
• Has any shareholder missed a due date?
• Has the company issued contribution notices?
• Has any creditor demanded accelerated contribution?
• Has capital been reduced?
• Are contributions tied to government incentives?
• Is the company solvent?

These should be answered with documents.

19. SPA drafting checklist#

Representations#

• capitalization;
• contribution history;
• no undisclosed obligation;
• no contribution dispute.

Covenants#

• amend articles;
• contribute before closing;
• preserve capital.

Conditions#

• registration completed;
• evidence delivered;
• lender consent.

Indemnity#

• historic unpaid capital;
• creditor claims;
• penalties.

Price#

• adjustment;
• escrow;
• holdback.

20. Post-closing governance#

After acquisition, the buyer should implement:

• capital calendar;
• board reporting;
• contribution evidence;
• registry update;
• finance control.

Do not let the obligation disappear into corporate records.

21. Seller-side preparation#

A seller preparing for auction should:

• clean capital history;
• collect evidence;
• resolve conflicting records;
• identify transition-rule action;
• prepare disclosure schedule.

This can materially improve transaction certainty.

22. The 2027 date should appear in the deal timetable#

For affected legacy companies, June 30, 2027 is not merely a compliance footnote.^[2]

If signing or closing overlaps the transition period, the transaction documents should specify who performs the required adjustment.

No deal team should reach June 2027 with the SPA silent on the issue.

23. Conclusion#

Unpaid subscribed capital is now a central M&A diligence topic.

The revised Company Law's five-year framework and the State Council's 2027 transition rule mean buyers must reconstruct contribution history, assess future funding and allocate the obligation contractually.^[1][2]

The practical rule is:

Do not price the equity until you have priced the unpaid capital.

A buyer that ignores the contribution gap may discover that part of the “purchase price” is effectively a future mandatory funding obligation.

24. The buyer should distinguish registered capital from total investment#

Foreign-invested industrial projects may use “total investment” concepts in historical approvals or incentive agreements that differ from registered capital.

The buyer should not assume that changing registered capital automatically changes every related project commitment.

Review:

• investment agreement;
• land contract;
• incentive document;
• bank financing;
• permits.

A capital reduction may trigger commercial consequences even if legally permissible.

25. Seller representations should cover historical compliance, not just current status#

A seller may truthfully state that the current articles show a future contribution date.

That does not answer whether:

• earlier due dates were missed;
• capital was withdrawn;
• contributions were fictitious;
• non-cash assets were defective.

Representations should cover the full history.

26. “Capital withdrawal” risk should be examined#

The diligence team should review whether shareholders contributed money and later extracted it through:

• unsupported loans;
• circular transactions;
• inflated related-party payments;
• asset transfers.

The legal characterization depends on facts.

But a buyer should not assume bank evidence of an initial deposit proves capital remained properly in the company.

27. Related-party receivables can hide funding problems#

A target may show paid-in capital while also having a large receivable from the shareholder.

The buyer should ask:

• why the receivable exists;
• whether money was transferred back;
• whether it is recoverable.

Economic substance matters.

28. The buyer should review corporate records for contribution enforcement#

The revised Company Law includes mechanisms concerning shareholder contribution duties.

The diligence should check:

• board records;
• shareholder notices;
• disputes.

If directors knew of unpaid contributions but did nothing, the buyer should understand governance exposure.

29. Solvency analysis is essential before relying on future due dates#

Even if the contribution date has not arrived, financial distress can change the risk.

The buyer should review:

• overdue creditors;
• enforcement cases;
• negative net assets;
• defaulted bank loans;
• tax arrears.

A distressed target can create accelerated funding pressure.

30. Purchase-price mechanics should avoid double counting#

Suppose enterprise value is RMB 100m and unpaid capital is RMB 30m.

The parties should define whether:

• seller funds the 30m;
• buyer funds after closing;
• enterprise value already assumes funding.

Without clarity, the buyer may pay full equity price and then inject additional capital.

The SPA's locked-box or completion accounts should be aligned.

31. Warranties need evidence schedules#

The seller should attach:

• capital table;
• contribution dates;
• payment evidence.

This reduces post-closing argument about what was disclosed.

A vague disclosure that “some capital remains unpaid” is insufficient if the economic amount is material.

32. Specific indemnity drafting should define the trigger#

A specific capital indemnity should state what loss is covered.

Potential triggers:

• company demand;
• creditor claim;
• authority penalty;
• required contribution;
• litigation cost.

The clause should also address:

• claim notice;
• defense control;
• cap;
• survival;
• security.

33. Escrow can be more useful than a damages claim#

If the seller is an individual who may move proceeds abroad, a post-closing indemnity can be difficult to collect.

Escrow or holdback can provide practical security.

The amount should be linked to quantified exposure.

34. Conditions precedent should be used for non-negotiable capital issues#

If the buyer cannot accept the capital risk, make remediation a condition to closing.

Examples:

• seller contributes;
• articles amended;
• registration completed;
• creditor issue resolved.

A covenant after closing is weaker.

35. The buyer should evaluate shareholder funding capacity#

If the seller promises to contribute RMB 30m before closing, confirm the seller can do it.

The SPA should require evidence and a long-stop date.

Do not rely on a promise that is financially unrealistic.

36. The 2027 transition can create a deal rush#

Many legacy companies may address capital structure as the deadline approaches.

Buyers in 2026–2027 should expect:

• article amendments;
• capital reductions;
• contribution accelerations.

Diligence should check whether recent changes were genuine and compliant.

37. Corporate registrations should be verified after remediation#

A seller may approve an amendment internally but fail to complete public registration.

Closing deliverables should include:

• updated articles;
• registry evidence;
• public disclosure.

The buyer should verify completion.

38. Joint-venture targets need minority-right review#

If the buyer acquires less than 100%, unpaid capital can interact with minority shareholders.

Questions:

• who funds future capital;
• dilution consequences;
• default remedies;
• pre-emption;
• board approval.

The shareholders agreement should align with statutory obligations.

39. Earn-outs should account for capital injections#

If the buyer's post-closing capital injection finances growth, an earn-out based on profit can become distorted.

The SPA should specify whether:

• capital costs;
• related-party financing;
• expansion expenses

affect the earn-out.

Capital structure and price mechanism should be coordinated.

40. Lender consents may be required#

Loan documents can contain:

• change of control;
• capital maintenance;
• shareholder funding.

The buyer should obtain lender consent before implementing capital changes.

41. Government incentive clawback can exceed the capital gap#

A target may have received incentives conditioned on investment level.

Reducing capital may trigger repayment larger than the capital savings.

Vendor diligence should quantify this.

42. Post-closing integration should not erase evidence#

The buyer should preserve:

• historical bank records;
• old articles;
• seller contribution evidence.

Do not destroy records during system migration.

They may be needed for future creditor claims.

43. Board reporting template after closing#

Report quarterly:

• registered capital;
• paid-in amount;
• next due date;
• responsible shareholder;
• funding status;
• regulatory filing.

This makes capital a managed obligation.

44. Deal-team red flags#

Escalate immediately if:

• huge registered capital vs small business;
• unclear contribution evidence;
• shareholder receivables;
• recent unexplained reduction;
• capital due shortly after closing;
• seller cannot fund.

These should affect price or structure.

45. Final acquisition rule#

The buyer should ask:

If every unpaid contribution became economically due tomorrow, who would fund it and how would that change the purchase price?

If the SPA does not answer that, the capital risk is not allocated.

46. The buyer should distinguish legal due diligence from financial working-capital analysis#

Unpaid capital can be confused with ordinary working-capital needs.

They are not the same.

Working capital is an operating funding requirement driven by inventory, receivables and payables. Registered capital is a statutory corporate funding commitment.

The buyer's financial model should show both separately.

Otherwise a buyer may think it is funding growth when part of the cash injection is actually satisfying a pre-existing shareholder obligation.

47. Closing accounts should identify shareholder funding after signing#

If the seller contributes capital between signing and closing, the SPA should specify how that contribution affects:

• cash;
• debt;
• working capital;
• purchase price.

A contribution can increase cash but should not create an artificial purchase-price windfall for the seller.

The completion accounts principles should address it explicitly.

48. Insurance does not replace capital-specific contractual protection#

Representations and warranties insurance may cover some corporate representations, depending on policy terms.

But buyers should not assume insurance will cover known unpaid capital.

Known issues are often excluded or specifically treated.

A known capital gap should be allocated directly in the SPA.

49. Management incentives can distort capital decisions#

If management receives a transaction bonus based on headline valuation, it may resist capital remediation that reduces the apparent equity price.

The board should evaluate net economics independently.

The relevant metric is: purchase price + required post-closing capital + identified liabilities.

50. The investment committee should receive a normalized equity price#

For targets with unpaid subscribed capital, present two prices:

• headline equity purchase price;
• normalized price after required capital funding.

This makes bids comparable.

A target offered for RMB 80 million with RMB 30 million required capital may be economically more expensive than a fully funded target offered for RMB 100 million.

Legal sources#

^[1] Company Law of the People's Republic of China (2023 Revision), effective July 1, 2024, including Articles 47–54 and related governance provisions: https://www.npc.gov.cn/npc/c2/c30834/202312/t20231229_433999.html

^[2] State Council Order No. 784, Provisions on Implementing the Registered Capital Registration Management System under the Company Law, especially Articles 2–3: https://xzfg.moj.gov.cn/front/law/detail?LawID=1727

This article is general legal information, not advice on a specific acquisition.